Statement Of Cash Flows [Abstract]

Zealand Pharma - Filing #1440145

Concept 2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2018-01-01 to
2018-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Increase (decrease) in working capital
97,818,000 DKK
10,873,000 DKK
12,785,000 DKK
Finance costs paid, classified as operating activities
4,562,000 DKK
3,390,000 DKK
16,705,000 DKK
Finance income received, classified as operating activities
895,000 DKK
5,413,000 DKK
4,263,000 DKK
Cash flows from (used in) investing activities [abstract]
Purchase of investments other than investments accounted for using equity method
0 DKK
22,803,000 DKK
225,719,000 DKK
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
42,706,000 DKK
14,444,000 DKK
22,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.